2.12 Angels’ investment thesis revolves around identifying and supporting early stage startups with disruptive potential, particularly in sectors such as technology, healthcare, and consumer products. The firm looks for visionary founders with innovative ideas that address large market opportunities. By investing in Seed and pre Seed rounds, 2.12 Angels focuses on businesses that have scalable business models and the potential for rapid growth.